Previous studies have shown that P. falciparum parasites in South America have undergone population bottlenecks resulting in clonal lineages that are differentially distributed and that have been responsible for several outbreaks different endemic regions. In this study, we explored the genomic profile of 18 P. falciparum samples collected in the Peruvian Amazon Basin (Loreto) and 6 from the Peruvian North Coast (Tumbes). Our results showed the presence of three subpopulations that matched previously typed lineages in Peru: Bv1 (n = 17), Clonet D (n = 4) and Acre-Loreto type (n = 3). Gene coverage analysis showed that none of the Bv1 samples presented coverage for pfhrp2 and pfhrp3. Genotyping of drug resistance markers showed a high prevalence of Chloroquine resistance mutations S1034C/N1042D/D1246Y in pfmdr1 (62.5%) and K45T in pfcrt (87.5%). Mutations associated with sulfadoxine and pyrimethamine treatment failure were found on 88.8% of the Bv1 samples which were triple mutants for pfdhfr (50R/51I/108N) and pfdhps (437G/540E/581G). Analysis of the pfS47 gene that allows P. falciparum to evade mosquito immune responses showed that the Bv1 lineage presented one pfS47 haplotype exclusive to Loreto and another haplotype that was present in both Loreto and Tumbes. Furthermore, a possible expansion of Bv1 was detected since 2011 in Loreto. This replacement could be a result of the high prevalence of CQ resistance polymorphisms in Bv1, which could have provided a selective advantage to the indirect selection pressures driven by the use of CQ for P. vivax treatment.
Malaria is an infectious disease caused by parasites of the Plasmodium genus that are transmitted through the bite of infected anopheline mosquitoes. This disease is widespread in tropical and subtropical regions causing more than 228 million cases and 405,000 deaths in 20181. The region of the Americas reported 929,000 cases and 577 deaths in 2018 with a population at risk of 138 million in 19 countries1.
Recently, South America has experienced a rise in malaria cases due to gold mining activities and increased transmission in Venezuela2,3. More than 90% of all malaria cases in the region were reported in Venezuela (51%), Brazil (23%), Colombia (10%) and Peru (6%)1.
In Peru, more than 95% of all malaria cases come from the North Eastern Amazon (Loreto region). In this region, Plasmodium vivax is more prevalent than P. falciparum at a ratio of 4:14. Malaria transmission is perennial in the country and the majority of affected people perform activities or live near rivers or natural water bodies5,6. Other malaria endemic areas are the Southern Amazon (Madre de Dios region) which is affected by illegal gold mining and the Pacific North Coast (Tumbes and Piura regions) where malaria transmission is intermittent7.
Although P. vivax has historically been prevalent in Peru, P. falciparum has expanded to different geographical areas. Until 1988, P. falciparum cases were only reported on the borders of Peru with Ecuador, Colombia and Brazil8. However, in 1991, 140 cases of P. falciparum were reported in Loreto and by 1994 the first cases were detected in Iquitos, the capital of the Loreto region and infections increased up to 54,290 cases in 19978. This expansion of cases was associated with the introduction of Anopheles darlingi, a highly competent anthropophagic vector, to Iquitos in 1991 and a rapid increase in abundance by 19944,8,9. Currently, An. darlingi and An. benarrochi are widely distributed in the Amazon region whereas An. albimanus is the prevalent vector in the North Coast10,11.
Another aspect that has characterized Loreto is the rapid emergence of drug resistant P. falciparum strains to chloroquine and sulfadoxine pyrimethamine12,13. In the early 1990’s, the first drug resistant cases were reported in Peru; chloroquine (CQ) resistance in the north coast and CQ and sulfadoxine-pyrimethamine (SP) in the Amazon region12. These results were used to implement SP as a first-line therapy to P. falciparum in the North Coast and demonstrated the presence of two different ecosystems in Peru. In 2001, Peruvian Government implemented a new malaria treatment scheme for P. falciparum based on artemisinin combination therapies (ACTs); Mefloquine-artesunate (AS) in the Amazon and AS-SP in the North Coast12,14.
Studies suggested the presence of three circulating P. falciparum lineages in Peru; two exclusively circulating in Loreto and a mixed lineage in both Loreto and the north coast15,16 . However, after the peak of malaria resurgence in Peru (between 1999 and 2000), molecular studies showed five circulating clonets (A, B, C, D and E) in the Peruvian territory15. All clonets were circulating in the Amazon region but only one in the North Coast (clonet E). Biodiversity analysis suggested that clonet E suffered a bottleneck and that only clonet B had evidence of rapid expansion. A subsequent analyses with samples from 2006–2007 showed evidence for the admixture of existing clonets due to outcrossing and appearance of new hybrid recombinants clonets such as B/C and C/D15.
In 2010–2012, one P. falciparum outbreak occurred in the North Coast of Peru five years after the elimination of malaria (no local P. falciparum transmission for 5 years was reported) in that region17. Epidemiological research showed that two of the first cases from this outbreak were from military personnel who were previously deployed in the Peruvian Amazon. Molecular typing showed that the North Coast samples were closely related but not completely identical to clonet B and thus were named as clonet B variant 1 (Bv1). This clonet variant presented point mutations in several drug resistance associated genes including pfdhfr, pfdhps, pfcrt and pfmdr1, as well as deletions on pfhrp217.
In 2013, another outbreak produced by P. falciparum Bv1 was reported in the region Cusco Region (southern of Peru) that did not present P. falciparum cases since 194618. A study conducted on samples from this outbreak suggested a potential introduction of Bv1 from the Peruvian Amazon18.
These outbreaks in distinct regions underscore the need for continuing surveillance of circulating parasites in Loreto, a region where P. falciparum lineages can spread to the rest of the country by human migration. In this study, we explored potential changes in circulating P. falciparum strains in Loreto in order to assess if the Bv1 clonet has replaced other P. falciparum circulating lineages in the Peruvian Amazon Basin and explore genotypic variants associated with drug resistance and virulence factors. The information provided by this study will serve to support control programs, current treatment regimens and regional malaria eradication efforts.
Samples were collected from the Peruvian Regions of Tumbes in the North Coast and Loreto in the Northern Amazon Basin (Fig. 1). Samples from Tumbes were collected between 2010 and 2011 whereas samples from Loreto were collected between 2006 until 2017.
Loreto presents a tropical climate with the rainy season from November to May and the dry season between June and October. Annual average temperature is 27 °C with more 80% humidity and average annual rainfall of 4 m.
Tumbes presents a tropical climate with the rainy season from January to April and the dry season between June and November. Annual average temperature is around 25 °C, 60% humidity and average annual rainfall of 175 mm.
The samples tested for this study were selected from two sources: (i) a passive surveillance study approved by the Institutional Review Board of the U.S Naval Medical Research Unit 6 (NAMRU-6) in compliance with all applicable federal regulations governing the protection of human subjects (protocol NMRCD.2007.0004) and (ii) a secondary data analysis with samples collected under outbreak and public health activities (NAMRU6.2018.0002) which did not involve humans as the subjects of the study evaluation. Informed consent was obtained from all participants and/or their legal guardians for study NMRCD.2007.0004. Informed consent was not required for NAMRU6.2018.0002 since it does not meet the definition of research involving human subjects per US Code of Federal Regulations, 32 CFR Part 219—PROTECTION OF HUMAN SUBJECTS, Section 219.104 Exempt research.
Blood samples were collected from suspected malaria patients and used to prepare slides for malaria diagnosis by microscopy. Positive samples were stored at −20 °C and then sent to NAMRU-6 Lima for DNA extraction and molecular testing. DNA was extracted from 200ul of whole blood using the QIAamp® DNA Blood Mini Kit (GmbH, Hilden, Germany) following the manufacturers protocol and stored at −20 °C. P. falciparum monoinfection was confirmed by a nested PCR that targets 18S small subunit ribosomal RNA (ssrRNA) gene19.
Selective whole genome amplification
Monoinfection samples were sequenced using whole genome amplification as previously described20. Briefly, we performed two amplification rounds with 50 ng of input DNA to a 50ul reaction mixture containing 5 μM SWGA primers (set 6A and 8A). Each amplification mix contained 30U phi29 DNA polymerase enzyme (New England Biolabs), phi29 DNA buffer (New England Biolabs), 1% bovine serum albumin, 1 mM dNTPs and water. The amplification reaction was carried out on a thermocycler and consisted of a ramp down from 35 to 30 °C during 10 min per degree, 16 h at 30 °C, 10 min at 65 °C and hold at 4 °C.
Amplified samples were diluted in 1:1 molecular grade water and purified using the Ampure XP (Beckman-Coulter) beads system at a ratio of 1:1 as per manufacturer’s protocol. Paired-end sequencing libraries were generated using 1 ng amplified DNA using the Nextera XT kit (Illumina, California, USA) following the manufacturer’s protocol. The pooled library was sequenced using the MiSeq reagent kit v3 (600 cycles) and MiSeq reagent kit v2 (500 cycles) and sequenced on an Illumina MiSeq sequencer to generate 250–300 bp paired end reads.
Read mapping and variant calling
Reads were quality filtered using Trimmomatic v0.36 with minimum base quality cutoff of 20, leading and trailing base qualities of 20, minimum per base average quality of 20 and a minimum read length of 70 bp21.
Filtered reads were competitively mapped onto the P. falciparum 3D7 (v33)22 and human reference (GRCh38.p13)23 genomes using Bowtie2 v2.3.524. Read depth information was used to estimate coverage for pfhrp2 and pfhrp3 for each sample.
Single nucleotide variants were jointly called from all samples using GATK v22.214.171.124 under the haplotype caller module and following the GATK best practices for variant calling25. Called variants were filtered using a mapping quality score greater than 40.0 and quality by depth greater than 2.0. SNP density was visualized with the BioCircos package implemented in R26. Genes located in highly polymorphic regions were extracted and used for gene ontology enrichment analysis on PlasmoDB27 using Bonferroni for correction for multiple testing to control significant results. Next generation sequencing data on drug resistance markers was complemented with Sanger sequencing results that were previously obtained17.
Analysis of diversity and selection
In order to assess the overall diversity at the individual and population level, we employed the FWS metric as previously described28. For this purpose, we called SNPs with SAMtools28 and employed moimix (https://github.com/bahlolab/moimix) to calculate the corresponding within-host heterozygosity (FWS).
Population scaled Tajima’s D was evaluated using a sliding window of 5 kb. Regions under selection were selected and the corresponding genes retrieved for gene ontology enrichment analysis using Bonferroni correction in PlasmoDB27.
In order to explore polymorphisms that could be associated with drug resistance, we employed the SnpEff tool30 to analyze the effects of SNPs in reported drug resistance genes.
Population structure and phylogenetic analyses
Filtered SNPs were subsequently used for discriminant analysis of principal components using the adegenet package implemented in R31. In order to provide additional information regarding the parasite population structure in these foci we used Admixture for estimating individual ancestries32. Admixture analyses were carried out using 10 independent Markov Chain Monte Carlo runs for each k of 1 to 10 under a tenfold cross-validation procedure with 1000 pseudoreplicates using different initial seed values for each K. We used Admixture’s cross-validation to select the most likely value of K and then employed pophelper to generate multiline plots33.
Filtered SNPs were used to assess the phylogenetic relationship of the isolates collected in Loreto and Tumbes. For this purpose, we generated a multiple sequence alignment in Seaview34 and phylogenetic reconstruction under a maximum likelihood approach in PhyML using the general time reversible model and 1000 pseudoreplicates35. Single nucleotides polymorphism of the S47 gene were individually analyzed by an haplotype network created in PopArt 1.736. In addition, relatedness between sample pairs was assessed by estimating the pairwise identity by descent (IBD) using hmmIBD with 100 iterations37. Samples were classified according to their IBD as highly-related (25–49%), very highly-related (50–75%) and clonal (> 75%). IBD networks were created according to time and collection site on cytoscape38.
Sample collection and whole genome sequencing
Blood samples were collected from 24 patients with P. falciparum monoinfection as determined by nested-PCR. Out of those, six samples were from the North Coast (collected during the outbreak in 2010–2011) and 18 from the Northern Amazon Basin (nine from 2006 to 2011 and nine from 2012 to 2017).
SWGA resulted in 24 high-quality P. falciparum whole genome sequences with an average of 2,492,353 reads per sample. Competitive read alignment against the P. falciparum 3D7 and human reference genomes resulted in an average 94.6% (SD: 4.7%) of reads aligning to the P. falciparum genome. The average read depth was of 20.47× (SD: 8.78×) with 52.43% (SD: 15.65%) of the nuclear genome covered by ≥ 5 reads (Table S1).
Chromosome SNP density
A total of 38,321 single nucleotide polymorphisms (SNPs) were called across all samples. Outlier regions with high SNP density were detected on chromosomes 1, 2, 4, 5, 7, 8, 11, 13 and 14 (Fig. 2). Gene enrichment analysis showed significant enrichment for molecular functions associated to host cell surface binding (Bonferroni-corrected p < 0.05) (Table S2).
Genomic wide scan using 5 kb sliding windows showed a tendency towards neutrality (mean Tajima's D = −0.5) (Fig. 2) with 61 chromosomic regions under selection (Table S3). All chromosomes but one (chromosome 7) presented a region under selection. Chromosomes 1, 2 and 3 only presented regions under positive selection whereas chromosomes 3 and 9 only under negative selection.
Regions under positive selection included genes members of the immunogenic variant surface antigens (rifin, stevor and EMP1) that have important roles in pathogenesis and immune evasion39. This information suggests that selective pressure on these parasites may lead to positive selection on diversity maintaining the heterozygosity pool in the population.
SNPEff showed that 0.11% of the variants had a high impact on their corresponding genes related to loss of function or protein truncation, 15.02% had a moderate impact associated with non-disruptive variant that might affect protein functionality, 6.73% presented a low impact (synonymous variant) and 78.12% modifier impact associated with non-coding variants or variants affecting non-coding genes (Table S4). Also, 184,692 transitions and 160,006 transversions were identified (Ts/Tv ratio: 1.15).
Gene ontology enrichment analysis showed statistical significance enrichment on genes suffering from moderate impact variants. Enrichment was associated with host cell surface binding, motor activity, sulfur compound binding, calmodulin binding and actin binding (Bonferroni-corrected p < 0.05) (Table S2).
The majority of samples collected from both study sites were monoclonal with only one polyclonal sample (FWS < 0.95) that was collected from the Peruvian Amazon Basin.
Drug resistance markers diversity
We identified widespread mutations associated with CQ and SP resistance in most isolates of the Peruvian Amazon Basin and North Coast (Table 1).
In pfmdr1, we found that 62.5% of the isolates (n = 15) presented the S1034C/N1042D/D1246Y triple mutation that is associated with CQ-resistance and increased susceptibility to mefloquine, halofantrine and artemisinin40. This genotype is enhanced by several mutations in the pfcrt gene including a change on exon two that is associated with CQ resistance (K76T)41.
The majority of Bv1-type samples (16 out of 18) were triple mutants for pfdhfr (50R/51I/108N) and pfdhps (437G/540E/581G). Such a combination of alleles is strongly associated to sulfadoxine and pyrimethamine treatment failure42.
None of the Peruvian samples presented mutations on pfk13, pfatg18, pfarps10 and ferredoxin that have been associated with artemisinin resistance45,46 nor pfexo which is associated with piperaquine47 nor pfmrp1 which is associated with sulfadoxine/pyrimethamine and artemether/lumefantrine resistance48.
Because of the high rates of pfhrp2 and pfhrp3 gene deletions in the Peruvian Amazon, we investigated the presence of these deletions in based on read depth. Our results show that none of the Bv1-type samples (n = 17) nor Acre-Loreto type (n = 3) presented coverage for pfhrp2 in contrast to three Clonet D (75%) samples that presented coverage along the gene (Fig. 3). In the case of pfhrp3, none of the of the Bv1-type samples (n = 17) presented coverage for this gene whereas two Clonet D (50%) and two Acre-Loreto (66.6%) presented coverage along the gene. All samples with read depth for these genes were collected between 2006 and 2011.
Principal component analysis and admixture revealed the presence of three parasite sub-populations and evidence of recombination between them in Peru (Fig. 4A and B). In the case of PCA, 47.3% of the variance was explained by the first two components. Admixture cross-validation for each clustering k from 1 to 10 showed that clustering with k = 4 presented the highest Delta K value (Figure S1 thus yielding three subpopulations in Peru.
The separation by PCA and admixture also showed three clusters in Peru. One consisting of a mixture of samples from the North Coast and the Amazon Basin (Bv1-type samples) whereas the other two clusters presented samples exclusively from the Amazon Basin (Clonet D and Acre-Loreto type) (Fig. 4B). This finding is supported by previous studies in Peru that indicate that the P. falciparum population is organized into up to 5 different clonal lineages which seem to be widely spread in the country with the highest level of admixture in the regions near Iquitos city15,17,18.
Whole genome maximum likelihood phylogenetic analysis matched the result from PCA and admixture showing that all samples collected since 2011 in the Peruvian Amazon Basin corresponded to the Bv1-type lineage (Fig. 5).
IBD analysis showed 80.5% of related sample pairs (IBD ≥ 25%) with 54.8% of them classified as highly-related pairs (IBD 25–49%), 22.9% as very highly-related (IBD 50–75%) and 2.7% as clonal (IBD > 75%) (Figure S2). IBD partitioned by geographical location showed 44.8% sample pairs of Loreto–Loreto, 44% of Loreto–Tumbes and 11.2% of Tumbes–Tumbes. In terms of time, there were 13.8% of IBD sample pairs from 2006/2010, 32.8% of IBD sample pairs from 2006/2010–2011/2017 and 53.4% of IBD sample pairs from 2011/2017 (Figure S2). In terms of drug resistance, 95.6% of IBD sample pairs were among Bv1 type samples.
The IBD network showed clustering according to the typed lineages (Bv1, Acre-Loreto and Clonet D) as well as the link between Loreto and Tumbes samples (Figure S3). Furthermore, IBD confirmed the population structure results from PCA and admixture and the hypothesis of Bv1 expansion as all sample pairs with more than 25% of the genome on IBD collected after 2011 in Loreto were among Bv1 (Figures S3and S4).
Molecular analyses of PfS47 gene
Peruvian samples were grouped into 11 PfS47 haplotypes of nonsynonymous mutations (Fig. 6, Table S5). The most prevalent haplotype was THILVL at positions 68, 194, 236, 242, 247 and 248 that was prevalent in 42% of the Peruvian samples (n = 10) (Fig. 6A). Control samples from Africa and Brazil were grouped into four haplotypes together with some of the Peruvian samples whereas a control reference from Asia (MRA1241) separated into a unique haplotype.
We found amino acid changes in two (236, 242) of the three (236, 242, 247) positions associated with invasion of mosquitos reported in previous studies49. We also found a change in position 68 with the amino acid threonine in all samples collected in Tumbes whereas samples from the Peruvian Amazon Basin presented threonine or methionine in this position (Fig. 6B).
Using the amino acid changes on regions associated with mosquito response evasion, we identified four PfS47 haplotypes in Peru named type 1 (TIL), type 2 (TTS), type 3 (MIL) and type 4 (MTS). The type 1 haplotype was found in seven Bv1-type samples isolated from the Peruvian Amazon Basin and the North Coast. The type 2 haplotype was found on four Bv1-types and one Acre-Loreto isolates from the Peruvian Amazon Basin. The type 3 and 4 corresponded to one Cloned D-type each isolated from the Peruvian Amazon Basin (Figure S5). The PfS47 Brazilian control presented the same structure as Peru type 1 whereas the Africa control the same as Peru type 2 (Fig. 6B). Analysis of diversity and selection showed that PfS47 in Peru is under positive selection (Tajima´s D = 1.44) although with a low diversity (π = 0.0015).
Evidence of positive selection on surface genes mediating host cell surface binding are an important result from this study and supports previous studies that indicate that immune pressure on parasites leads to positive selection on diversity maintaining the pool of heterozygotes in the population50. This adaptive mechanism could have important consequences for the development of effective vaccines against these parasites due to the risk of high polymorphism on putative vaccine candidates.
However, it is important to note that Peru is a low malaria transmission region with low parasite recombination rates and highly clonal populations15,17,51. These populations are prone to demographic size changes derived from introduction, drug selection pressure, malaria control, eradication strategies and genetic drift as previously shown15,18. Therefore, results derived from neutral hypothesis tests such as Tajima´s D test should be interpreted with caution52.
During the last three decades, malaria rates in Peru have fluctuated overtime because of malaria control initiatives, changes in treatment regimens, migration and climatic variables. These different factors have exerted selection pressure on the parasite population. Our results of molecular drug resistance profiles show that although SP and CQ are no longer used to treat P. falciparum in Peru, drug resistance associated mutations in pfmdr1 and pfcrt appear to be maintained in the parasite population pool throughout time. In this regard, it has been previously suggested that the low prevalence of pfcrt wild type strains would limit the recovery of sensitive CQ resistant parasites even in the absence of CQ15,53 in contrast to what has been shown in Africa54.
However, it is also possible that P. falciparum strains in Peru are subjected to indirect selection pressures to CQ as a result of CQ based treatment for P. vivax infections. Therefore, P. falciparum could be exposed to CQ during treatment of misdiagnosed mixed infections or as a result of inadequate diagnosis. In the case of SP, the majority of the Bv1-type samples were triple mutants for pfdhfr and pfdhps which is consistent with the first reports of P. falciparum foreign lineages in the Peruvian territory55.
None of the tested samples presented mutations associated to artemisinin resistance in pfk13. This result is consistent with reports from other countries in the region and is an important finding given the threat of potential emergence of artemisinin resistance in the Guyana shield56 and the high migration rates across all the region as a result of the Venezuela crisis and illegal activities conducted across the triple border of Brazil, Venezuela and Guayana57,58. Circulating Peruvian strains harbor low frequency polymorphisms outside the propeller domain such as the K189T mutation that has been originally reported in Africa and subsequently in Brazil, Venezuela and French Guyana59,60.
Our study has shown the presence to three P. falciparum subpopulations one of which (Bv1-type) was present in both regions whereas the other two were present only in the Peruvian Amazon. These lineages seem to be related to previously reported clonets that appeared to be widespread in Peru15,55. The long-term persistence of these lineages for near two decades could be linked to a bottleneck that resulted from the strong selective pressure from the introduction of artesunate combination therapies in Peru, the low mosquito Human Blood Index and the characteristics of the Peru as a low transmission region in contrast with transmission patterns seen in Africa. This finding is further supported by the low number of polyclonal infections, which reduce the chances of genetic outcrossing and recombination. Therefore, these characteristics of malaria transmission in Peru limit increased parasite diversity or the emergence of more virulent and resistant strains.
The Bv1-dhfr profile (50R/51I/108N) was found by the first time in isolates from Bolivia (1994) and then in samples from Brazil (1997) and Venezuela (1998)61. Studies in Peru did not report the Bv1-dhfr profile until 2006 when it was detected in samples from the Amazon Basin55. Our population structure and phylogenetic analysis show that this Bv1-type lineage has become predominant in the Peruvian Amazon Basin since 2011.This lineage presents several drug resistance associated polymorphisms, which might have provided a selective advantage to the indirect selective pressure of CQ for treatment for P. vivax in the region. In this regard, further studies with increased sample size and geographic coverage are needed to confirm the Bv1-type lineage expansion in the region.
The Bv1 line has a history of contributing to two major outbreaks in Peru. The first one in in the Peruvian North Coast in 2010–201217 and the other one in the region of Cusco in 201318. Interestingly, the potential strain replacement suggested by our study in the Peruvian Amazon occurred during a period of rapid increase in the number of P. falciparum cases in the Amazon Basin raising from 2600 cases to 10,200 between 2011 and 2014.
The potential spread and increase in the number of cases could be due to the fact that the Bv1 line presents a high frequency of pfhrp2 and pfhrp3 gene deletions17,18. Our data further indicates that deletions have been sustained overtime with none of the more recent Bv1 samples presenting coverage for both genes. The absence of pfhrp2 and pfhrp3 constitutes a major challenge for malaria elimination in Peru given the use of RDTs for malaria diagnosis. In this regard, previous studies conducted in Peru have shown up to 41% of pfhrp2 gene deletions and RDTs sensitivities between 50 to 70% compared to microscopy or PCR62,63.
The potential replacement of circulating lineages by the Bv1 lineage parasites in Loreto and Colombia where it has been previously reported64,65 seems to suggest that this line is highly adaptable to different transmission settings. In this regard, it is important to point out that Anopheles darlingi and Anopheles oswaldoi are reported malaria vectors in the Amazonas Department in Colombia66 whereas Anopheles darlingi and Anopheles benarrochi are the among the main vectors in the Peruvian Amazon Basin. In contrast, Anopheles albimanus is the main vector in the Peruvian North coast and Anopheles pseudopunctipennis in the Department of Cusco. Therefore, there is evidence to point out that the Bv1-type lineage is able to adapt to a wide range of malaria vectors that could allow it to expand in different endemic settings.
The mosquito immune system have an important role preventing the transmission of the parasite. In response to this threat, the parasite evades mosquito immune response through different mechanisms. One of these mechanisms appears to be linked to the PfS47 gene that allows the parasite to evade mosquito immune detection by disrupting JNK signaling in invaded midgut cells and blocking TEP1-mediated killing67,68.
In vivo studies associated that some PfS47 haplotypes can mediate the invasion of different anopheline species evading their immune response69,70. Furthermore, genetic studies have shown evidence of PfS47 mediated vector-parasite compatibility that limits the parasite to specific vector species70 in a “lock-and-key” model. This limitation is in an important barrier for P. falciparum infection and transmission as a result of purifying selection mediated by anopheline species70.
In this regard, we report three positions on PfS47 gene (68, 236 and 242) that are probably associated with evasion of the anopheline´s immune response in our region. Out of the four Peruvian PfS47 haplotypes the Pfs47 type1 (TIL) was detected in the North Coast and the Amazon Basin. Furthermore, the Brazilian control PfS47 haplotype was similar to the Peruvian PfS47 type1 whereas the African control the same as the Peruvian PfS47 type 2. The compatibility of PfS47 haplotypes with the Brazilian lineage is in alignment with hypothesis of introduction of Bv1 from Brazil around 2006 (V. Udhayakumar, unpublished) and highlights the possibility of future introduction of drug resistant lineages from Brazil or Africa.
The presence of Bv1 in areas with different malaria vectors highlight the need to conduct further research to explore the PfS47 gene variants of and other virulence markers that could have facilitated the spread of Bv1 through Peru and other endemic regions.
Although our sample size is rather limited, our findings provide grounds for additional studies with larger sample sizes that could provide additional evidence of this change in the parasite population in Peru. In this regard, further research is needed to assess the effects of recent migration waves, malaria control activities and the impact of COVID19 on public health in the transmission of malaria in Peru.
The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government.
Several authors of this paper are employees of the U.S. Government. This work was prepared as part of their official duties. Title 17 U.S.C. §105 provides that ‘Copyright protection under this title is not available for any work of the United States Government.’ Title 17 U.S.C. §101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties.
The dataset generated during and/or analyzed during the current study is available from the corresponding author on reasonable request. Raw sequence data has been deposited at the European Nucleotide Archive (https://www.ebi.ac.uk/ena/browser/home) under primary accession number PRJEB46168.
Organization, W. H. World malaria report 2019. (2019).
Grillet, M. E. et al. Malaria in Southern Venezuela: the hottest hotspot in Latin America. PLoS Negl Trop Dis 15, e0008211. https://doi.org/10.1371/journal.pntd.0008211 (2021).
Louzada, J. et al. The impact of imported malaria by gold miners in Roraima: characterizing the spatial dynamics of autochthonous and imported malaria in an urban region of Boa Vista. Mem Inst Oswaldo Cruz 115, e200043. https://doi.org/10.1590/0074-02760200043 (2020).
Rosas-Aguirre, A. et al. Epidemiology of Plasmodium vivax Malaria in Peru. Am. J. Trop. Med. Hyg. 95, 133–144. https://doi.org/10.4269/ajtmh.16-0268 (2016).
Branch, O. et al. Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar. J. 4, 27. https://doi.org/10.1186/1475-2875-4-27 (2005).
Rosas-Aguirre, A. et al. Hotspots of malaria transmission in the peruvian amazon: rapid assessment through a parasitological and serological survey. PLoS ONE 10, e0137458. https://doi.org/10.1371/journal.pone.0137458 (2015).
Sanchez, J. F. et al. Unstable malaria transmission in the Southern Peruvian amazon and its association with gold mining, Madre de Dios, 2001–2012. Am. J. Trop. Med. Hyg. 96, 304–311. https://doi.org/10.4269/ajtmh.16-0030 (2017).
Aramburu Guarda, J., Ramal Asayag, C. & Witzig, R. Malaria reemergence in the Peruvian Amazon region. Emerging infectious diseases 5, 209–215, doi:https://doi.org/10.3201/eid0502.990204 (1999).
Roper, M. H. et al. The epidemiology of malaria in an epidemic area of the Peruvian Amazon. Am. J. Trop. Med. Hyg. 62, 247–256. https://doi.org/10.4269/ajtmh.2000.62.247 (2000).
Flores-Mendoza, C., Fernandez, R., Escobedo-Vargas, K. S., Vela-Perez, Q. & Schoeler, G. B. Natural Plasmodium infections in Anopheles darlingi and Anopheles benarrochi (Diptera: Culicidae) from eastern Peru. J. Med. Entomol. 41, 489–494. https://doi.org/10.1603/0022-2585-41.3.489 (2004).
Guthmann, J. P., Llanos-Cuentas, A., Palacios, A. & Hall, A. J. Environmental factors as determinants of malaria risk. A descriptive study on the northern coast of Peru. Trop. Med Int Health : TM & IH 7, 518–525, doi:https://doi.org/10.1046/j.1365-3156.2002.00883.x (2002).
Williams, H. A., Vincent-Mark, A., Herrera, Y. & Chang, O. J. A retrospective analysis of the change in anti-malarial treatment policy: Peru. Malar. J. 8, 85. https://doi.org/10.1186/1475-2875-8-85 (2009).
Ruebush, T. K. 2nd. et al. Chloroquine-resistant Plasmodium vivax malaria in Peru. Am. J. Trop. Med. Hyg. 69, 548–552 (2003).
Ruebush, T. K. 2nd., Neyra, D. & Cabezas, C. Modifying national malaria treatment policies in Peru. J. Public Health Policy 25, 328–345. https://doi.org/10.1057/palgrave.jphp.3190032 (2004).
Griffing, S. M. et al. South American Plasmodium falciparum after the malaria eradication era: clonal population expansion and survival of the fittest hybrids. PLoS ONE 6, e23486. https://doi.org/10.1371/journal.pone.0023486 (2011).
Huaman, M. C. et al. Polymorphism of the Plasmodium falciparum multidrug resistance and chloroquine resistance transporter genes and in vitro susceptibility to aminoquinolines in isolates from the Peruvian Amazon. Am. J. Trop. Med. Hyg. 70, 461–466 (2004).
Baldeviano, G. C. et al. Molecular epidemiology of plasmodium falciparum Malaria Outbreak, Tumbes, Peru, 2010–2012. Emerg. Infect. Dis. 21, 797–803. https://doi.org/10.3201/eid2105.141427 (2015).
Okoth, S. A. et al. Molecular investigation into a malaria outbreak in Cusco, Peru: plasmodium falciparum BV1 lineage is linked to a second outbreak in recent times. Am. J. Trop. Med. Hyg. 94, 128–131. https://doi.org/10.4269/ajtmh.15-0442 (2016).
Snounou, G. et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 61, 315–320. https://doi.org/10.1016/0166-6851(93)90077-b (1993).
Sundararaman, S. A. et al. Genomes of cryptic chimpanzee Plasmodium species reveal key evolutionary events leading to human malaria. Nat. Commun. 7, 11078. https://doi.org/10.1038/ncomms11078 (2016).
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120. https://doi.org/10.1093/bioinformatics/btu170 (2014).
Gardner, M. J. et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498–511. https://doi.org/10.1038/nature01097 (2002).
Schneider, V. A. et al. Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly. Genome Res. 27, 849–864 (2017).
Langdon, W. B. Performance of genetic programming optimised Bowtie2 on genome comparison and analytic testing (GCAT) benchmarks. BioData mining 8, 1. https://doi.org/10.1186/s13040-014-0034-0 (2015).
McKenna, A. et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20, 1297–1303. https://doi.org/10.1101/gr.107524.110 (2010).
Team, R. C. R: A language and environment for statistical computing. (2013).
Aurrecoechea, C. et al. PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res. 37, D539–D543 (2009).
Auburn, S. et al. Characterization of within-host Plasmodium falciparum diversity using next-generation sequence data. PloS one 7 (2012).
Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6, 80–92. https://doi.org/10.4161/fly.19695 (2012).
Jombart, T. adegenet: a R package for the multivariate analysis of genetic markers. Bioinformatics 24, 1403–1405 (2008).
Alexander, D. H. & Lange, K. Enhancements to the ADMIXTURE algorithm for individual ancestry estimation. BMC Bioinformatics 12, 246 (2011).
Francis, R. M. pophelper: an R package and web app to analyse and visualize population structure. Mol. Ecol. Resour. 17, 27–32 (2017).
Gouy, M., Guindon, S. & Gascuel, O. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol. 27, 221–224 (2010).
Guindon, S., Delsuc, F., Dufayard, J. F. & Gascuel, O. Estimating maximum likelihood phylogenies with PhyML. Methods Mol. Biol. 537, 113–137. https://doi.org/10.1007/978-1-59745-251-9_6 (2009).
Leigh, J. W. & Bryant, D. Popart: full-feature software for haplotype network construction. Methods Ecol. Evol. 6, 1110–1116 (2015).
Schaffner, S. F., Taylor, A. R., Wong, W., Wirth, D. F. & Neafsey, D. E. hmmIBD: software to infer pairwise identity by descent between haploid genotypes. Malar. J. 17, 196. https://doi.org/10.1186/s12936-018-2349-7 (2018).
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498–2504. https://doi.org/10.1101/gr.1239303 (2003).
Frech, C. & Chen, N. Variant surface antigens of malaria parasites: functional and evolutionary insights from comparative gene family classification and analysis. BMC Genomics 14, 427. https://doi.org/10.1186/1471-2164-14-427 (2013).
Sidhu, A. B., Valderramos, S. G. & Fidock, D. A. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol 57, 913–926. https://doi.org/10.1111/j.1365-2958.2005.04729.x (2005).
Wellems, T. E. & Plowe, C. V. Chloroquine-resistant malaria. J Infect Dis 184, 770–776. https://doi.org/10.1086/322858 (2001).
Picot, S. et al. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar. J. 8, 89. https://doi.org/10.1186/1475-2875-8-89 (2009).
Cubides, J. R. et al. Simultaneous detection of Plasmodium vivax dhfr, dhps, mdr1 and crt-o resistance-associated mutations in the Colombian Amazonian region. Malar. J. 17, 130. https://doi.org/10.1186/s12936-018-2286-5 (2018).
Kublin, J. G. et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 185, 380–388. https://doi.org/10.1086/338566 (2002).
Breglio, K. F. et al. A single nucleotide polymorphism in the Plasmodium falciparum atg18 gene associates with artemisinin resistance and confers enhanced parasite survival under nutrient deprivation. Malar. J. 17, 391. https://doi.org/10.1186/s12936-018-2532-x (2018).
Miotto, O. et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet 47, 226–234. https://doi.org/10.1038/ng.3189 (2015).
Boonyalai, N. et al. Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization. Malar. J. 19, 269. https://doi.org/10.1186/s12936-020-03339-w (2020).
Rijpma, S. R. et al. MRP1 mediates folate transport and antifolate sensitivity in Plasmodium falciparum. FEBS Lett 590, 482–492. https://doi.org/10.1002/1873-3468.12079 (2016).
Molina-Cruz, A., Canepa, G. E. & Barillas-Mury, C. Plasmodium P47: a key gene for malaria transmission by mosquito vectors. Curr Opin Microbiol 40, 168–174. https://doi.org/10.1016/j.mib.2017.11.029 (2017).
Branch, O. H. et al. Plasmodium falciparum genetic diversity maintained and amplified over 5 years of a low transmission endemic in the Peruvian Amazon. Mol Biol Evol 28, 1973–1986. https://doi.org/10.1093/molbev/msq311 (2011).
Anderson, T. J. et al. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol 17, 1467–1482. https://doi.org/10.1093/oxfordjournals.molbev.a026247 (2000).
Tajima, F. The effect of change in population size on DNA polymorphism. Genetics 123, 597–601 (1989).
McCollum, A. M., Mueller, K., Villegas, L., Udhayakumar, V. & Escalante, A. A. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob Agents Chemother 51, 2085–2091. https://doi.org/10.1128/AAC.01228-06 (2007).
Mekonnen, S. K. et al. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia. Malar. J. 13, 244. https://doi.org/10.1186/1475-2875-13-244 (2014).
Bacon, D. J. et al. Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrob Agents Chemother 53, 2042–2051. https://doi.org/10.1128/AAC.01677-08 (2009).
Chenet, S. M. et al. Independent emergence of the plasmodium falciparum Kelch propeller domain mutant allele C580Y in Guyana. J Infect Dis 213, 1472–1475. https://doi.org/10.1093/infdis/jiv752 (2016).
Douine, M. et al. Predictors of antimalarial self-medication in illegal gold miners in French Guiana: a pathway towards artemisinin resistance. J Antimicrob Chemother 73, 231–239. https://doi.org/10.1093/jac/dkx343 (2018).
Musset, L. et al. Malaria on the Guiana Shield: a review of the situation in French Guiana. Mem Inst Oswaldo Cruz 109, 525–533. https://doi.org/10.1590/0074-0276140031 (2014).
Pacheco, M. A. et al. Malaria in Venezuela: changes in the complexity of infection reflects the increment in transmission intensity. Malar. J. 19, 176. https://doi.org/10.1186/s12936-020-03247-z (2020).
Torrentino-Madamet, M. et al. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012–2013. Malar. J. 13, 472. https://doi.org/10.1186/1475-2875-13-472 (2014).
Cortese, J. F., Caraballo, A., Contreras, C. E. & Plowe, C. V. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis 186, 999–1006. https://doi.org/10.1086/342946 (2002).
Bendezu, J. et al. Field evaluation of a rapid diagnostic test (Parascreen) for malaria diagnosis in the Peruvian Amazon. Malar. J. 9, 154. https://doi.org/10.1186/1475-2875-9-154 (2010).
Maltha, J. et al. Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of pfhrp2 gene deletions and cross-reactions. PLoS ONE 7, e43094. https://doi.org/10.1371/journal.pone.0043094 (2012).
Murillo Solano, C. et al. Deletion of plasmodium falciparum Histidine-rich protein 2 (pfhrp2) and histidine-rich protein 3 (pfhrp3) genes in Colombian parasites. PLoS ONE 10, e0131576. https://doi.org/10.1371/journal.pone.0131576 (2015).
Dorado, E. J. et al. Genetic characterisation of plasmodium falciparum isolates with deletion of the pfhrp2 and/or pfhrp3 Genes in Colombia: the Amazon Region, a challenge for malaria diagnosis and control. PLoS ONE 11, e0163137. https://doi.org/10.1371/journal.pone.0163137 (2016).
Rodriguez, M. et al. Composition and biting activity of Anopheles (Diptera: Culicidae) in the Amazon region of Colombia. J. Med. Entomol. 46, 307–315. https://doi.org/10.1603/033.046.0215 (2009).
Molina-Cruz, A. et al. The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system. Science 340, 984–987. https://doi.org/10.1126/science.1235264 (2013).
Ramphul, U. N., Garver, L. S., Molina-Cruz, A., Canepa, G. E. & Barillas-Mury, C. Plasmodium falciparum evades mosquito immunity by disrupting JNK-mediated apoptosis of invaded midgut cells. Proc Natl Acad Sci USA 112, 1273–1280. https://doi.org/10.1073/pnas.1423586112 (2015).
Molina-Cruz, A., Zilversmit, M. M., Neafsey, D. E., Hartl, D. L. & Barillas-Mury, C. Mosquito vectors and the globalization of plasmodium falciparum malaria. Annu Rev Genet 50, 447–465. https://doi.org/10.1146/annurev-genet-120215-035211 (2016).
Molina-Cruz, A. et al. Plasmodium evasion of mosquito immunity and global malaria transmission: the lock-and-key theory. Proc Natl Acad Sci U S A 112, 15178–15183. https://doi.org/10.1073/pnas.1520426112 (2015).
We would like to thank Dr. Dan Vivas from UNMSM and Dr. Venkatachalam Udhayakumar from the CDC Malaria Branch for their support in reviewing the article. This manuscript was made from FV's thesis work to obtain a master's degree in Molecular Biology at the Faculty of Biological Sciences of the Universidad Mayor de San Marcos.
This work was supported by the US DoD Armed Forces Health Surveillance Division, Global Emerging Infections Surveillance Section (AFHSD/GEIS), 2020–2021, PROMIS ID P0144_20_N6_02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Villena, F.E., Lizewski, S.E., Joya, C.A. et al. Population genomics and evidence of clonal replacement of Plasmodium falciparum in the Peruvian Amazon. Sci Rep 11, 21212 (2021). https://doi.org/10.1038/s41598-021-00806-5